Stocks

The latest stocks coverage from the TrustFinance editorial desk.

Latest in Stocks
UBS Upgrades DocMorris to Neutral on Improving Margin Outlook

Stocks

UBS Upgrades DocMorris to Neutral on Improving Margin Outlook

Jul 20, 2026

UBS has raised its rating on online pharmacy DocMorris to 'Neutral' from 'Sell,' citing a developing track record of margin improvement and a more favorable sales mix. The bank also significantly increased its price target, though it remains cautious on the company's path to positive free cash flow.